Update on biologic safety for patients with psoriasis during pregnancy
Biologic agents have become more common to treat patients with psoriasis, but concerns about their effect on pregnancy and lactation often preclude this treatment during these time periods. During the past decade, we have gained a much better understanding of the course of psoriasis during pregnancy...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-03-01
|
Series: | International Journal of Women's Dermatology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352647516300375 |
id |
doaj-92d6a49769bb4de2b0bb82d589796eb7 |
---|---|
record_format |
Article |
spelling |
doaj-92d6a49769bb4de2b0bb82d589796eb72020-11-25T01:07:49ZengElsevierInternational Journal of Women's Dermatology2352-64752017-03-01312125Update on biologic safety for patients with psoriasis during pregnancyMartina L. Porter0Stephen J. Lockwood1Alexa B. Kimball2Clinical Unit for Research Trials and Outcomes in Skin (CURTIS), Massachusetts General Hospital, Boston, MAClinical Unit for Research Trials and Outcomes in Skin (CURTIS), Massachusetts General Hospital, Boston, MADepartment of Dermatology, Harvard Medical School, MA; Harvard Medical Faculty Physicians, Beth Israel Deaconess Medical Center, Boston, MA; Corresponding author.Biologic agents have become more common to treat patients with psoriasis, but concerns about their effect on pregnancy and lactation often preclude this treatment during these time periods. During the past decade, we have gained a much better understanding of the course of psoriasis during pregnancy and the safety of the use of biologic agents during pregnancy and lactation. Under certain circumstances, biologic agents can be considered appropriate treatment options for patients who are pregnant or lactating. Keywords: psoriasis, pregnancy, lactation, biologic agents, TNF-alpha inhibitorshttp://www.sciencedirect.com/science/article/pii/S2352647516300375 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Martina L. Porter Stephen J. Lockwood Alexa B. Kimball |
spellingShingle |
Martina L. Porter Stephen J. Lockwood Alexa B. Kimball Update on biologic safety for patients with psoriasis during pregnancy International Journal of Women's Dermatology |
author_facet |
Martina L. Porter Stephen J. Lockwood Alexa B. Kimball |
author_sort |
Martina L. Porter |
title |
Update on biologic safety for patients with psoriasis during pregnancy |
title_short |
Update on biologic safety for patients with psoriasis during pregnancy |
title_full |
Update on biologic safety for patients with psoriasis during pregnancy |
title_fullStr |
Update on biologic safety for patients with psoriasis during pregnancy |
title_full_unstemmed |
Update on biologic safety for patients with psoriasis during pregnancy |
title_sort |
update on biologic safety for patients with psoriasis during pregnancy |
publisher |
Elsevier |
series |
International Journal of Women's Dermatology |
issn |
2352-6475 |
publishDate |
2017-03-01 |
description |
Biologic agents have become more common to treat patients with psoriasis, but concerns about their effect on pregnancy and lactation often preclude this treatment during these time periods. During the past decade, we have gained a much better understanding of the course of psoriasis during pregnancy and the safety of the use of biologic agents during pregnancy and lactation. Under certain circumstances, biologic agents can be considered appropriate treatment options for patients who are pregnant or lactating. Keywords: psoriasis, pregnancy, lactation, biologic agents, TNF-alpha inhibitors |
url |
http://www.sciencedirect.com/science/article/pii/S2352647516300375 |
work_keys_str_mv |
AT martinalporter updateonbiologicsafetyforpatientswithpsoriasisduringpregnancy AT stephenjlockwood updateonbiologicsafetyforpatientswithpsoriasisduringpregnancy AT alexabkimball updateonbiologicsafetyforpatientswithpsoriasisduringpregnancy |
_version_ |
1725185035784421376 |